Fundraising FoxBiologics
Fayetteville, US · Delaware corporation · 3 known investors
Find your way into Biologics
Sign up to find every way you can get introduced to Biologics
- Your email: who you already know at Biologics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biologics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.
Founders & leadership
JD
J. David OwensExecutive
RG
Robyn GoforthNamed on SEC filing
RG
Rob GensureNamed on SEC filing
Board
RB
Ramsay BallBoard director
CG
Calvin GoforthBoard director
LK
Lynn KirkpatrickBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$400K disclosed across 1 round · 2016
▶$400KraisedFeb 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$400KraisedFeb 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ramsay BallDirector
- Robyn GoforthExecutive Officer
- Calvin GoforthDirector, Promoter
- Rob GensureExecutive Officer
- J. David OwensExecutive Officer, Director
- Lynn KirkpatrickDirector
- Offering amount
- $7M
- Amount sold
- $400K
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Macrogenics IncMacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
WazeWorld's largest community-based traffic and navigation app.
AbiologicsAbiologics uses computational design tools to create protein-inspired molecules called Synteins, engineered to avoid the vulnerabilities of natural protein medicines while retaining biological function. The company develops these molecules as a new class of therapeutics with the aim of advancing candidates toward clinical development.
AdvanceCTAdvanceCT is a nonprofit economic development organization that drives job creation and capital investment in Connecticut through business attraction, retention, and expansion. It works with state and local partners to support inclusive business development and provide companies with resources, workforce solutions, and research.
Companies working in the same space as Biologics.
Frequently asked questions
- What does Biologics do?
- BiologicsMD is a preclinical therapeutic company developing patent-protected recombinant fusion proteins that target the parathyroid hormone receptor for treatments in hair loss, bone disorders, and oncology. Its proteins combine an active stimulatory domain with a binding domain to localize therapy at the disease site for targeted, infrequent dosing.
- Who are Biologics's investors?
- Biologics's investors include Connecticut Innovations, Houston Angel Network, Robin Hood Ventures.
- How much funding has Biologics raised?
- Biologics has disclosed $400K raised across 1 round.
- Where is Biologics headquartered?
- Biologics is headquartered in Fayetteville, US.